Alfuzosin

xPharm: The Comprehensive Pharmacology Reference

Volumn , Issue , 2007, Pages 1-4

  Michel, Martin C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883914627     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008055232-3.63088-0     Document Type: Chapter

References (10)

1. Forray C., Bard J.A., Wetzel J.M., Chiu G., Shapiro E., Tang R., Lepor H., Hartig P.R., Weinshank R.L., Branchek T.L., Gluchowski C. The alpha1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alphaC subtype. Molecular Pharmacology 1994, 45:703-708.
2. Michel M.C., Flannery M.T., Narayan P. Worldwide experience with alfuzosin and tamsulosin. Urology 2001, 58(4):508-516.
3. Michel M.C., Grubbel B., Taguchi K., Verfurth F., Otto T., Kropfl D. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha1-adrenoceptor subtypes and in human prostate. Journal of Autonomic Pharmacology 1996, 16(1):21-28.
4. Michel M.C. Potential role of alpha1-adrenoceptor subtypes in the aetiology of LUTS. European Urology Supplements 2002, 1(9):5-13.
5. Weiner D.M., Lowe F.C. Alfuzosin for the management of benign prostate hyperplasia. Expert Opinion in Pharmacotherapy 2003, 4(11):2057-2063.
6. McKeage K., Plosker G.L. Alfuzosin. A review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia. Drugs 2002, 62(4):633-653.
7. Wilde M.I., Fitton A., McTavish D. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs 1993, 45(3):410-429.
8. Buzelin J.M., Roth S., Geffriaud-Ricouard C., Delauche-Cavallier M.C. Efficacy and safety of sustained release alfuzosin 5 mg in patients with benign prostatic hyperplasia. European Urology 1997, 31:191-198.
9. Martin D.J., Lluel P., Guillot E., Coste A., Jammes D., Angel I. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists. Journal of Experimental Pharmacology and Therapeutics 1997, 282:228-235.
10. Lefevre-Borg F., O'Connor S.E.O., Schoemaker H., Hicks P.E., Lechaire J., Gautier E., Pierre F., Pimoule C., Manoury P., Langer S.Z. Alfuzosin, a selective alpha1-adrenoceptor antagonist in the lower urinary tract. British Journal of Pharmacology 1993, 109:1282-1289.